Kataoka, Hiroshi
Watanabe, Saki
Sato, Masayo
Manabe, Shun
Makabe, Shiho
Akihisa, Taro
Ushio, Yusuke
Iwasa, Naomi
Yoshida, Rie
Tsuchiya, Ken
Nitta, Kosaku
Mochizuki, Toshio http://orcid.org/0000-0002-3820-3191
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP 15K09279)
Article History
Received: 6 January 2021
Accepted: 8 March 2021
First Online: 2 April 2021
Declarations
:
: Toshio Mochizuki and Ken Tsuchiya received travel fees and honoraria for lectures from Otsuka Pharmaceutical Co. Toshio Mochizuki and Hiroshi Kataoka belong to an endowed department sponsored by Otsuka Pharmaceutical Co., Chugai Pharmaceutical Co., Kyowa Hakko Kirin Co., and JMS Co.
: The study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2008 and approved by the Research Ethics Committee of Tokyo Women’s Medical University (No. 196B).
: Not applicable.
: Not applicable.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.
: Informed consent was obtained from all patients to participate in the study.
: Informed consent was obtained from all patients to be included in this manuscript.
: The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.